Mizuho Upgrades Valeant, Says Financial Engineering Helped Company 'Outfox The Shorts'
August 15, 2016 at 09:50 AM EDT
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) reported Q2 results with the revenue and EPS missing expectations. Mizuho’s Irina ...